Shakeri, A., & Adanty, C. (2020). Romosozumab (sclerostin monoclonal antibody) for the treatment of osteoporosis in postmenopausal women: A review. Journal of Population Therapeutics and Clinical Pharmacology, 27(1), e25-e31. https://doi.org/10.15586/jptcp.v27i1.655